Lawrence, KS, United States of America

Lauren Miranda Fox


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lauren Miranda Fox: Innovator in Therapeutic Compounds

Introduction

Lauren Miranda Fox is a prominent inventor based in Lawrence, KS (US). She has made significant contributions to the field of therapeutic compounds, particularly through her innovative work on Toll-like receptor 8 agonists. Her research focuses on the development of compounds that can be utilized for various therapeutic purposes.

Latest Patents

Lauren Miranda Fox holds a patent for Toll-like receptor 8 agonists. The compounds described in her patent can be used for therapeutic purposes, including as adjuvants in vaccines. These compounds can be TLR agonists, such as TLR8 agonists, and can be included in pharmaceutical compositions. The pharmaceutical compositions may contain various ingredients, such as carriers, diluents, excipients, fillers, or other common components. The compounds can also include derivatives, prodrugs, salts, stereoisomers, tautomers, polymorphs, solvates, or combinations thereof.

Career Highlights

Lauren is affiliated with the University of Kansas Medical Center Research Institute, where she continues her research and development of innovative therapeutic solutions. Her work has the potential to impact various medical fields, particularly in vaccine development and other therapeutic applications.

Collaborations

Some of her notable coworkers include Sunil Abraham David and Hari Prasad Kokatla, who contribute to her research endeavors and collaborative projects.

Conclusion

Lauren Miranda Fox is a dedicated inventor whose work on Toll-like receptor 8 agonists showcases her commitment to advancing therapeutic solutions. Her contributions to the field are significant and hold promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…